has global count value
- 8
CitationCount for Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Global Citation Count
- Overview
Overview
has global count date
- February 6, 2026 1:03 PM